Chemotherapy-induced Nausea and Vomiting

• FDA approval · 2006-12-26
  FDA Approved: ONDANSETRON — Original Application (Dr. Reddy's Laboratories Limited)

  FDA approved the original ANDA for ondansetron hydrochloride from Dr. Reddy's Laboratories Limited. The product is indicated for the prevent…

• FDA approval · 2006-08-23
  FDA Approved: PALONOSETRON HYDROCHLORIDE — Supplemental Application (Cipla USA Inc.)

  FDA approved a supplemental application for palonosetron hydrochloride submitted by Cipla USA Inc., reflecting an approved change to the pro…

• FDA approval · 2006-06-30
  FDA Approved: EMEND — Supplemental Application (Merck Sharp & Dohme LLC)

  FDA approved a supplemental application for EMEND (aprepitant) by Merck Sharp & Dohme LLC, updating the product labeling to reflect its anti…

• FDA approval · 2006-06-21
  FDA Approved: DRONABINOL — Supplemental Application (Ascend Laboratories, LLC)

  FDA approved a supplemental application for dronabinol (Dronabinol) submitted by Ascend Laboratories, LLC. The product is used for chemother…

• FDA approval · 2006-06-09
  FDA Approved: EMEND — Supplemental Application (Merck Sharp & Dohme LLC)

  This document covers a supplemental application for EMEND (aprepitant) submitted by Merck Sharp & Dohme LLC to the FDA.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2006-05-15
  FDA Approved: CESAMET — Supplemental Application (Bausch Health US LLC)

  The FDA approved a supplemental application for Cesamet (nabilone) from Bausch Health US LLC, indicating an additional regulatory action for…